AAAAAA
Results: 1-25/35
Authors:
COUILLARD S
LABRIE C
BELANGER A
CANDAS B
POULIOT F
LABRIE F
Citation: S. Couillard et al., EFFECT OF DEHYDROEPIANDROSTERONE AND THE ANTIESTROGEN EM-800 ON GROWTH OF HUMAN ZR-75-1 BREAST-CANCER XENOGRAFTS, Journal of the National Cancer Institute, 90(10), 1998, pp. 772-778
Authors:
LUO SQ
LABRIE C
BELANGER A
CANDAS B
LABRIE F
Citation: Sq. Luo et al., PREVENTION OF DEVELOPMENT OF DIMETHYLBENZ(A)ANTHRACENE (DMBA)-INDUCEDMAMMARY-TUMORS IN THE RAT BY THE NEW NONSTEROIDAL ANTIESTROGEN EM-800(SCH57050), Breast cancer research and treatment, 49(1), 1998, pp. 1-11
Authors:
LABRIE F
BELANGER A
LUUTHE V
LABRIE C
SIMARD J
CUSAN L
GOMEZ JL
CANDAS B
Citation: F. Labrie et al., DHEA AND THE INTRACRINE FORMATION OF ANDROGENS AND ESTROGENS IN PERIPHERAL TARGET TISSUES - ITS ROLE DURING AGING, Steroids, 63(5-6), 1998, pp. 322-328
Authors:
LAFLAMME N
NAPPI RE
DROLET G
LABRIE C
RIVEST S
Citation: N. Laflamme et al., EXPRESSION AND NEUROPEPTIDERGIC CHARACTERIZATION OF ESTROGEN-RECEPTORS (ER-ALPHA AND ER-BETA) THROUGHOUT THE RAT-BRAIN - ANATOMICAL EVIDENCE OF DISTINCT ROLES OF EACH SUBTYPE, Journal of neurobiology, 36(3), 1998, pp. 357-378
Authors:
HARTEL C
SOURLA A
PELLETIER C
LABRIE C
FOURNIER M
PICARD S
LI S
STOJANOVIC M
LABRIE F
Citation: C. Hartel et al., PREDOMINANT ANDROGENIC COMPONENT IN THE STIMULATORY EFFECT OF DEHYDROEPIANDROSTERONE ON BONE-MINERAL DENSITY IN THE RAT, Journal of Endocrinology, 157(3), 1998, pp. 433-442
Authors:
MARTEL C
LABRIE C
BELANGER A
GAUTHIER S
MERAND Y
LI X
PROVENCHER L
CANDAS B
LABRIE F
Citation: C. Martel et al., COMPARISON OF THE EFFECTS OF THE NEW ORALLY-ACTIVE ANTIESTROGEN EM-800 WITH ICI-182-780 AND TOREMIFENE ON ESTROGEN-SENSITIVE PARAMETERS IN THE OVARIECTOMIZED MOUSE, Endocrinology, 139(5), 1998, pp. 2486-2492
Authors:
LUO SQ
SOURLA A
LABRIE C
GAUTHIER S
MERAND Y
BELANGER A
LABRIE F
Citation: Sq. Luo et al., EFFECT OF 24-WEEK TREATMENT WITH THE ANTIESTROGEN EM-800 ON ESTROGEN-SENSITIVE PARAMETERS IN INTACT AND OVARIECTOMIZED MICE, Endocrinology, 139(5), 1998, pp. 2645-2656
Authors:
SOURLA A
MARTEL C
LABRIE C
LABRIE F
Citation: A. Sourla et al., ALMOST EXCLUSIVE ANDROGENIC ACTION OF DEHYDROEPIANDROSTERONE IN THE RAT MAMMARY-GLAND, Endocrinology, 139(2), 1998, pp. 753-764
Authors:
TREMBLAY A
TREMBLAY GB
LABRIE C
LABRIE F
GIGUERE V
Citation: A. Tremblay et al., EM-800, A NOVEL ANTIESTROGEN, ACTS AS A PURE ANTAGONIST OF THE TRANSCRIPTIONAL FUNCTIONS OF ESTROGEN-RECEPTOR-ALPHA AND ESTROGEN-RECEPTOR-BETA, Endocrinology, 139(1), 1998, pp. 111-118
Authors:
COUILLARD S
GUTMAN M
LABRIE C
BELANGER A
CANDAS B
LABRIE F
Citation: S. Couillard et al., COMPARISON OF THE EFFECTS OF THE ANTIESTROGENS EM-800 AND TAMOXIFEN ON THE GROWTH OF HUMAN BREAST ZR-75-1 CANCER XENOGRAFTS IN NUDE-MICE, Cancer research, 58(1), 1998, pp. 60-64
Authors:
BLAIS A
LABRIE Y
POULIOT F
LACHANCE Y
LABRIE C
Citation: A. Blais et al., STRUCTURE OF THE GENE ENCODING THE HUMAN CYCLIN-DEPENDENT KINASE INHIBITOR P18 AND MUTATIONAL ANALYSIS IN BREAST-CANCER, Biochemical and biophysical research communications, 247(1), 1998, pp. 146-153
Authors:
LUO SQ
MARTEL C
CHEN CL
LABRIE C
CANDAS B
SINGH SM
LABRIE F
Citation: Sq. Luo et al., DAILY DOSING WITH FLUTAMIDE OR CASODEX EXERTS MAXIMAL ANTIANDROGENIC ACTIVITY, Urology, 50(6), 1997, pp. 913-919
Authors:
LABRIE F
LUUTHE V
LIN SX
LABRIE C
SIMARD J
BRETON R
BELANGER A
Citation: F. Labrie et al., THE KEY ROLE OF 17-BETA-HYDROXYSTEROID DEHYDROGENASES IN SEX STEROID BIOLOGY, Steroids, 62(1), 1997, pp. 148-158
Authors:
GAUTHIER S
CARON B
CLOUTIER J
DORY YL
FAVRE A
LAROUCHE D
MAILHOT J
OUELLET C
SCHWERDTFEGER A
LEBLANC G
MARTEL C
SIMARD J
MERAND Y
BELANGER A
LABRIE C
LABRIE F
Citation: S. Gauthier et al., RIDINYL)ETHOXY]PHENYL]-2H-1-BENZOPYRAN-3-YL]PHENYL 2,2-DIMETHYLPROPANOATE (EM-800) - A HIGHLY POTENT, SPECIFIC, AND ORALLY-ACTIVE NONSTEROIDAL ANTIESTROGEN()), Journal of medicinal chemistry, 40(14), 1997, pp. 2117-2122
Authors:
LUO SQ
MARTEL C
GAUTHIER S
MERAND Y
BELANGER A
LABRIE C
LABRIE F
Citation: Sq. Luo et al., LONG-TERM INHIBITORY EFFECTS OF A NOVEL ANTIESTROGEN ON THE GROWTH OFZR-75-1 AND MCF-7 HUMAN BREAST-CANCER TUMORS IN NUDE-MICE, International journal of cancer, 73(5), 1997, pp. 735-739
Authors:
LUO SQ
STOJANOVIC M
LABRIE C
LABRIE F
Citation: Sq. Luo et al., INHIBITORY EFFECT OF THE NOVEL ANTIESTROGEN EM-800 AND MEDROXYPROGESTERONE ACETATE ON ESTRONE-STIMULATED GROWTH OF DIMETHYLBENZ[A]ANTHRACENE-INDUCED MAMMARY-CARCINOMA IN RATS, International journal of cancer, 73(4), 1997, pp. 580-586
Authors:
LUO SQ
MARTEL C
SOURLA A
GAUTHIER S
MERAND Y
BELANGER A
LABRIE C
LABRIE F
Citation: Sq. Luo et al., COMPARATIVE EFFECTS OF 28-DAY TREATMENT WITH THE NEW ANTIESTROGEN EM-800 AND TAMOXIFEN ON ESTROGEN-SENSITIVE PARAMETERS IN INTACT MICE, International journal of cancer, 73(3), 1997, pp. 381-391
Authors:
SIMARD J
LABRIE C
BELANGER A
GAUTHIER S
SINGH SM
MERAND Y
LABRIE F
Citation: J. Simard et al., CHARACTERIZATION OF THE EFFECTS OF THE NOVEL NONSTEROIDAL ANTIESTROGEN EM-800 ON BASAL AND ESTROGEN-INDUCED PROLIFERATION OF T-47D, ZR-75-1AND MCF-7 HUMAN BREAST-CANCER CELLS IN-VITRO, International journal of cancer, 73(1), 1997, pp. 104-112
Authors:
LUO SQ
LABRIE C
BELANGER A
LABRIE F
Citation: Sq. Luo et al., EFFECT OF DEHYDROEPIANDROSTERONE ON BONE MASS, SERUM-LIPIDS, AND DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-CARCINOMA IN THE RAT, Endocrinology, 138(8), 1997, pp. 3387-3394
Authors:
SOURLA A
LUO SQ
LABRIE C
BELANGER A
LABRIE F
Citation: A. Sourla et al., MORPHOLOGICAL-CHANGES INDUCED BY 6-MONTH TREATMENT OF INTACT AND OVARIECTOMIZED MICE WITH TAMOXIFEN AND THE PURE ANTIESTROGEN EM-800, Endocrinology, 138(12), 1997, pp. 5605-5617
Authors:
LUO SQ
SOURLA A
LABRIE C
BELANGER A
LABRIE F
Citation: Sq. Luo et al., COMBINED EFFECTS OF DEHYDROEPIANDROSTERONE AND EM-800 ON BONE MASS, SERUM-LIPIDS, AND THE DEVELOPMENT OF DIMETHYLBENZ(A)ANTHRACENE-INDUCED MAMMARY-CARCINOMA IN THE RAT, Endocrinology, 138(10), 1997, pp. 4435-4444
Authors:
SIMARD J
SANCHEZ R
POIRIER D
GAUTHIER S
SINGH SM
MERAND Y
BELANGER A
LABRIE C
LABRIE F
Citation: J. Simard et al., BLOCKADE OF THE STIMULATORY EFFECT OF ESTROGENS, OH-TAMOXIFEN, OH-TOREMIFENE, DROLOXIFENE, AND RALOXIFENE ON ALKALINE-PHOSPHATASE ACTIVITY BY THE ANTIESTROGEN EM-800 IN HUMAN ENDOMETRIAL ADENOCARCINOMA ISHIKAWA CELLS, Cancer research, 57(16), 1997, pp. 3494-3497
Authors:
LUO S
MARTEL C
LEBLANC G
CANDAS B
SINGH SM
LABRIE C
SIMARD J
BELANGER A
LABRIE F
Citation: S. Luo et al., RELATIVE POTENCIES OF FLUTAMIDE AND CASODEX - PRECLINICAL STUDIES, Endocrine-related cancer, 3(3), 1996, pp. 229-241
Authors:
LABRIE F
BELANGER A
CUSAN L
LABRIE C
SIMARD J
LUUTHE V
DIAMOND P
GOMEZ JL
CANDAS B
Citation: F. Labrie et al., HISTORY OF LHRH AGONIST AND COMBINATION THERAPY IN PROSTATE-CANCER, Endocrine-related cancer, 3(3), 1996, pp. 243-278
Authors:
POIRIER D
MERAND Y
LABRIE C
LABRIE F
Citation: D. Poirier et al., D-RING ALKYLAMIDE DERIVATIVES OF ESTRADIOL - EFFECT ON ER-BINDING AFFINITY AND ANTIESTROGENIC ACTIVITY, Bioorganic & medicinal chemistry letters, 6(21), 1996, pp. 2537-2542